Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Prices of 50 essential drugs slashed by up to 44 percent

      Prices of 50 essential drugs slashed by up to 44 percent

      supriya kashyap kashyap25 Dec 2016 11:07 AM IST
      New Delhi : Prices of over 50 essential drugs including those used for treatment of HIV infection, diabetes, anxiety disorders, bacterial infections,...
      FDA approves Biogen drug for lead genetic cause of infant death

      FDA approves Biogen drug for lead genetic cause of infant death

      supriya kashyap kashyap25 Dec 2016 11:05 AM IST
      The U.S. Food and Drug Administration said it has approved Biogen Inc's drug to treat spinal muscular atrophy, the leading genetic cause of death in...
      Colombia cuts price of Novartis cancer drug by 44 percent

      Colombia cuts price of Novartis cancer drug by 44 percent

      supriya kashyap kashyap25 Dec 2016 11:05 AM IST
      Colombia's government has lowered the price of Novartis cancer drug imatinib by nearly half in a bid to cut healthcare costs after failed price...
      USFDA subjects SPARC Xelpros nod to satisfactory resolution

      USFDA subjects SPARC Xelpros nod to satisfactory resolution

      supriya kashyap kashyap25 Dec 2016 9:53 AM IST
      New Delhi : Sun Pharma Advanced Research Company (SPARC) said the US health regulator has not approved its new drug application for Xelpros, a...
      Teva to pay 519 M dollars to settle bribery allegations

      Teva to pay 519 M dollars to settle bribery allegations

      supriya kashyap kashyap25 Dec 2016 9:49 AM IST
      Israel's Teva Pharmaceutical said on Thursday it had agreed to pay $519 million to settle charges it violated the US Foreign Corrupt Practices Act...
      Roches emicizumab haemophilia drug succeeds in trial

      Roches emicizumab haemophilia drug succeeds in trial

      supriya kashyap kashyap24 Dec 2016 3:06 PM IST
      Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said.Roche is hoping to win a...
      Sun Pharma to acquire oncology product from Novartis for $175 million

      Sun Pharma to acquire oncology product from Novartis for $175 million

      supriya kashyap kashyap24 Dec 2016 9:42 AM IST
      New Delhi : Drug major Sun Pharmaceutical Industries said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment...
      Med Achievers targets USD 100 million Business from Europe

      Med Achievers targets USD 100 million Business from Europe

      supriya kashyap kashyap24 Dec 2016 9:40 AM IST
      New Delhi : Med Achievers the first of its kind platform in healthcare innovation and global technology incubator in India has facilitated the entry...
      Indian pharma eyes pride of place, regulation Achilles heel

      Indian pharma eyes pride of place, regulation Achilles heel

      supriya kashyap kashyap24 Dec 2016 9:21 AM IST
      New Delhi : India is on track to cement its position next year as a source of safe, effective and quality medicines at affordable prices, but a...
      Giovanni Caforio Named Chairman of Bristol-Myers Squibbs Board of Directors

      Giovanni Caforio Named Chairman of Bristol-Myers Squibbs Board of Directors

      supriya kashyap kashyap23 Dec 2016 12:41 PM IST
      New York : Bristol-Myers Squibb Company announced that the company’s Board of Directors has appointed Giovanni Caforio, M.D. as chairman of the board,...
      USFDA approves tissue expander breast reconstruction after mastectomy

      USFDA approves tissue expander breast reconstruction after mastectomy

      supriya kashyap kashyap23 Dec 2016 12:38 PM IST
      The U.S. Food and Drug Administration allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction...
      GSKs two-drug HIV therapy shines in two big studies

      GSK's two-drug HIV therapy shines in two big studies

      supriya kashyap kashyap23 Dec 2016 12:31 PM IST
      London : GlaxoSmithKline's already fast-growing HIV drug business has received an important boost with the success of two major clinical studies...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok